The management of unresectable hepatocellular carcinoma (HCC) involves recognizing and managing adverse events and effectively working with a multidisciplinary team. This Clinical ForumSM brings together an interventional radiologist, oncologist, and hepatologist to discuss how they work together at their institutions to achieve a common goal.
Upon completion of this activity, participants should be better able to:
Professor
Memorial Sloan Kettering Cancer Center
New York, NY
Radiologist
Memorial Hospital for Cancer and Allied Diseases
New York, NY
David Bruton Jr. Professor in Clinical Cancer Research
Associate Professor, Medicine
Medical Director, Liver Tumor Program
Clinical Chief, Hepatology
University of Texas Southwestern
Dallas, TX
Featured RMEI CE Activities – Earn CE Credit(s)
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources